
    
      We propose to conduct a 13 week randomized, controlled clinical trial to evaluate the safety
      and efficacy of ondansetron and naltrexone alone and in combination.Eligible subjects will be
      randomized to placebo, ondansetron, naltrexone, or ondansetron + naltrexone treatments. All
      subjects will receive a weekly CBT (Cognitive Behavioral Therapy)sessions.
    
  